The preclinical evidence obtained by other researchers [106]—in lower airway dysbiosis induced by aspiration of oral commensals—has confirmed that the direct blocking of the IL-17 pathway using anti-IL-17 monoclonal antibodies can slow tumor growth. The gene discussed is IL17A; the disease is neoplasm.